StockStory Highlights ResMed and StoneX as Mid-Cap Picks, Flags US Foods as Underperformer

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory identifies ResMed and StoneX as mid-cap stocks with exciting potential, while recommending investors avoid US Foods. ResMed, a developer of cloud-connected respiratory medical devices, posted average constant currency revenue growth of 9.1% over the past two years and annual earnings per share growth of 15.2% over five years, with its free cash flow margin expanding by 21.4 percentage points. StoneX, a global financial services network, achieved 44.3% annual revenue growth and 29.6% annual earnings per share growth over the last two years, alongside 16.9% annual tangible book value per share growth over five years. In contrast, US Foods, a major foodservice distributor, showed only 2.4% average unit sales growth over two years, substandard operating margins, and a lack of free cash flow generation, limiting reinvestment potential.

Impact on stocks 3

Cloud & Digital Infrastructure▲ · 1 stocks
ResMed Inc
RMD
▲ PositiveCapitalrelevance

StockStory highlights ResMed's strong revenue and earnings growth, and expanding free cash flow margin, recommending it as a mid-cap pick.

Digital Finance & Tokenization▲ · 1 stocks
Stonex Group Inc
SNEX
▲ PositiveCapitalrelevance

StockStory highlights StoneX's high revenue and earnings growth, and tangible book value growth, recommending it as a mid-cap pick.

Consumer Staples▼ · 1 stocks
US Foods Holding Corp
USFD
▼ NegativeCapitalrelevance

StockStory flags US Foods as an underperformer due to low unit sales growth, substandard margins, and lack of free cash flow.

© 2026 MarketDXNews